Recent Interviews

Lewis Black, CEO, Almonty Industries

Lewis Black
CEO | Almonty Industries
100 King Street West, M5X 1C7 Toronto (CAN)

+1 (647) 438-9766

Interview with mine operator Almonty Industries: "Tungsten makes e-cars better"

Nick Luksha, President, Prospect Ridge Resources

Nick Luksha
President | Prospect Ridge Resources
1288 West Cordova Street Suite 2807, V6C 3R3 Vancouver (CAN)

Interview Prospect Ridge Resources: These fillets taste good to the market

Dirk Graszt, CEO, Clean Logistics SE

Dirk Graszt
CEO | Clean Logistics SE
Trettaustr.32, 21107 Hamburg (DE)


Interview Clean Logistics: Hydrogen challenge to Daimler + Co.

19. November 2021 | 13:13 CET

Sativa Wellness Group, Aurora Cannabis, TUI - Rising consumer spending on wellness and travel

  • Cannabis
Photo credits:

According to Statista, the health and wellness market is worth around EUR 105 billion. More than USD 900 billion is spent annually worldwide on beauty and antiaging alone. Spending on travel is also increasing significantly after a sharp drop in the wake of the Corona pandemic. Reason enough to take a look at three stocks of industry representatives. Who is making the running?

time to read: 4 minutes by Carsten Mainitz



Carsten Mainitz

The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

About the author

Sativa Wellness Group - Another step closer to its lofty goals

The legalization of cannabis has created an industry worth billions. Sativa Wellness wants to cut itself a piece of this pie and set itself very lofty goals in the process. The Company intends to become one of the leading manufacturers and high-quality distributors of CBD and wellness products and services in Europe. Elemental to this is the implementation of full vertical integration of supply chains and the expansion of the distribution network.

Currently, Sativa is focused on the UK, operating in three business areas. CBD products for consumers are offered under the Goodbody Botanicals brand. With its subsidiary PhytoVista, the Group operates CBD and hemp testing laboratories. Goodbody Wellness clinics provide testing services - including COVID testing - for clinics, as well as direct-to-consumer and direct-to-business services via a telemedicine consultation service. Sativa now has more than 80 clinics in operation. Most recently, it announced a distribution partnership in Germany.

Recently, the Company announced a partnership with Superdrug Stores to offer a full range of blood testing services. The agreement includes 40 Superdrug locations where trained nurses draw blood for a range of tests. Customers order the test they want on the Goodbody Clinic website. They can then choose to have a personal blood test, select a Superdrug clinic or use one of the participating Goodbody stores to collect the blood. Commenting on the new developments, Geremy Thomas, Executive Chairman, said, "Our Goodbody clinics' partnership with Superdrug for wellness blood testing expands the options for customers. It allows them to have the test they want at a location that is convenient for them and allows them to take control of their wellness."

The Company continues to exceed the goals it has set for itself, reflected in its most recently released quarterly data. Over the same quarter last year, third-quarter revenue was up 977% to CAD 8.6 million, nearly a tenfold increase. Gross profit increased to CAD 4.59 million, with an even slightly higher rate of growth. The gross profit margin was reported at the previous year's level of 53%. After a loss of CAD 1.19 million, the Company managed to be in the black with a net profit of CAD 14,000 in Q3. The Company has a moderate valuation level with a stock market value of around CAD 26 million.

TUI - The USA opens its doors again for travelers

For a few days now, it has been possible for EU citizens to enter the USA again, provided they have been fully vaccinated and have tested negative for the coronavirus. The German Lufthansa stated that there is great demand, and it expects a load factor on the pre-crisis level in the coming weeks.

Christmas shopping in New York or a beach vacation in Florida attracts many tourists to the United States. "We see a significant catch-up effect in travel, both in short-term bookings, especially by couples and small groups for November and December, and in long-term trips by families during the Easter and summer vacations," explained newly appointed TUI Germany CEO, Stefan Baumert.

This news has completely bypassed the share. In the first quarter, the share certificates still cost around EUR 4.50 at times, and now EUR 2 less is being called on the stock exchange. That means that the Group is still valued at EUR 2.8 billion. The average analyst estimates for 2021 are sales of EUR 5.6 billion and a loss of EUR 2.2 billion. The turnaround is expected to occur in 2022, when experts anticipate sales of EUR 16 billion and a return to the black, with profits of EUR 234 million. Overall, analysts currently rate the stock as "hold".

Aurora Cannabis Inc - Can the world's number two finally take off thanks to a reduced quarterly loss?

Canadian Company Aurora Cannabis, based in Edmonton, Alberta, is the world's second-largest cannabis producer. With a market capitalization of around CAD 1.9 billion, the Company has an 8.74% stake in the Prime Alternative Harvest Index, just behind market leader Tilray (8.96%). The producer of medical and consumer cannabis products, which has been in the red for years, has recently come under pressure on the stock market, like other cannabis stocks. But there is light at the end of the tunnel.

Aurora managed to narrow its loss to CAD -0.06 in the past quarter, down from CAD -0.90 in the corresponding quarter last year. Analysts had forecast a loss of CAD -0.256. After the announcement of the figures, the share price increased by up to 7%. One reason for the friendly attitude of investors is likely to be rooted in the expectation that there could soon be federal marijuana legislation in the US, which could allow companies like Aurora Cannabis to access regular services, especially in the banking sector.

In anticipation of an imminent solution in the US, Aurora had already acquired Reliva LLC. in 2020, one of the largest US producers of CBD products. It is also in line with the strategy of the new CEO Miguel Martin, in office since September last year, to focus on profitable markets and niches in the future. This focus definitely makes sense.

All three of the stocks mentioned above are benefiting from rising consumer spending in the fields of wellness, health and travel. TUI is an attractive turnaround story at the current share price level. Sativa Wellness Group offers an exciting investment story at a moderate valuation. If Aurora manages to reduce its loss further, the stock is also worth a look.


Carsten Mainitz

The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

About the author

Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.

Related comments:

11. November 2021 | 13:02 CET | by Fabian Lorenz

Bayer, TUI, Sativa Wellness: Figures move share prices

  • Cannabis

The reporting season is drawing to a close. Overall, most companies have been convincing, and the stock markets have been very friendly in recent weeks. Bayer published positive quarterly figures, raised its forecast for the full year and thus convinced the analysts from DZ Bank. Sativa Wellness benefits from the boom around cannabis and CBD. The still-new boom is growing strongly and is already in the black. At TUI, the operating figures play less of a role. The development of the Corona figures and, thus, possible travel restrictions in the coming winter are more critical. Read more about all three shares here.


28. October 2021 | 12:04 CET | by André Will-Laudien

Canopy, Tilray, Sativa Wellness, Formycon - Finding the next cannabis rocket!

  • Cannabis

The big bull market in cannabis ran through 2018 and 2019, and then in 2020, the reality set in that only a fraction of states around the world will implement general licensing for hemp. The newly elected federal parliament has its first constituent session these days. Climate change and investments in digital infrastructure are two of the most important topics in the coalition negotiations to form a new federal government. One topic that is not quite so high on the list of priorities, but is already causing a lot of excitement in the run-up, is the possible legalization of cannabis. The Greens and FDP have been advocating legal, regulated trade for some time. Of course, nothing has been decided yet, but the outgoing federal government's drug commissioner, Daniela Ludwig of the CSU, already warns of the consequences. We take a look at important industry representatives.


26. October 2021 | 11:37 CET | by Stefan Feulner

Tilray, Ayurcann, Aurora Cannabis, Canopy Growth - Sow first, then reap

  • Cannabis

After the hype around cannabis companies like Aurora Cannabis, Tilray and Canopy Growth in 2018, consolidation followed, and it continues. But the industry is moving mightily. Smaller companies disappeared from the price list, while big players expanded their market power through mergers and acquisitions for the next few years. The cannabis industry is predicted to grow tremendously in the future. The fantasy is fueled by government legalization plans in several states, including Germany.